MetLife Investment Management’s Preformed Line Products PLPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Buy
1,477
+16
+1% +$5.61K ﹤0.01% 1801
2026
Q1
$396K Hold
1,461
– – ﹤0.01% 1864
2025
Q4
$302K Hold
1,461
– – ﹤0.01% 2062
2025
Q3
$287K Hold
1,461
– – ﹤0.01% 2115
2025
Q2
$233K Hold
1,461
– – ﹤0.01% 2112
2025
Q1
$205K Sell
1,461
-49
-3% -$6.66K ﹤0.01% 2189
2024
Q4
$193K Hold
1,510
– – ﹤0.01% 2322
2024
Q3
$193K Hold
1,510
– – ﹤0.01% 2307
2024
Q2
$188K Buy
1,510
+154
+11% +$19.7K ﹤0.01% 2286
2024
Q1
$174K Hold
1,356
– – ﹤0.01% 2268
2023
Q4
$182K Hold
1,356
– – ﹤0.01% 2291
2023
Q3
$220K Hold
1,356
– – ﹤0.01% 2151
2023
Q2
$212K Hold
1,356
– – ﹤0.01% 2240
2023
Q1
$174K Hold
1,356
– – ﹤0.01% 2299
2022
Q4
$113K Hold
1,356
– – ﹤0.01% 2544
2022
Q3
$96.5K Buy
+1,356
New +$95.5K ﹤0.01% 2689
2018
Q3
– Sell
-1,536
Closed -$136K – 2627
2018
Q2
$136K Buy
+1,536
New +$114K ﹤0.01% 2107

Other funds holding PLPC

MetLife Investment Management's PLPC Position: Q2 2026 in Review

MetLife Investment Management increased its Preformed Line Products (PLPC) stake by 1.1% in Q2 2026, buying an estimated $5.61K and bringing the position to 1,477 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

MetLife Investment Management first reported a position in PLPC in Q2 2018 and has held it in 17 quarters since. 206 funds tracked by Wall St. Rank hold PLPC as of Q2 2026.

  • MetLife Investment Management held 1,477 shares of Preformed Line Products worth $606K as of Q2 2026.
  • MetLife Investment Management bought 16 Preformed Line Products shares in Q2 2026, an estimated $5.61K.
  • Preformed Line Products made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1801 holding.
  • MetLife Investment Management first reported a position in Preformed Line Products in Q2 2018 and has held it in 17 quarters since.
  • 206 funds tracked by Wall St. Rank held Preformed Line Products as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.